Search

everythinglearnresearchcommunity

for

Search:↓

Androgens affect skin conditions like acne and hirsutism, treatable with hormone therapy and other methods.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Estrogen treatments can cause unwanted effects in men and should be used cautiously.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Spironolactone can reduce hair growth in women with hirsutism.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

5α-reductase-2 deficiency causes ambiguous genitalia at birth and affects male sexual development, but individuals often develop male characteristics at puberty.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

The document concludes that hirsutism in women, often caused by PCOS, requires systematic evaluation and can be treated with medications, mechanical removal, or cosmetic methods, with weight loss also being beneficial.

Testosterone increases hair growth and acne in transgender men.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Transgender patients with hair loss need personalized treatment plans considering their unique needs.

Hormone replacement therapy improves skin health and reduces aging signs in postmenopausal women.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

A postmenopausal woman's hormone imbalance and symptoms improved after removing benign ovarian tumors.

The treatment effectively reduces menopausal symptoms and is well tolerated.

Topical finasteride didn't significantly reduce facial hair, but patients felt it helped.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

Hirsutism can be treated with medications or hair removal methods, tailored to each person.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.